Head-to-head · WeighScore
AM Rx vs Wellorithm
The verdict
AM Rx takes it — 49.6/100 to 48.5/100, but only just.
AM Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. AM Rx (getamrx.com) is a telehealth platform operated by FitRX, LLC (also operates Zealthy and FitRx). Wellorithm is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | AM Rx | Wellorithm |
|---|---|---|
| WeighScore | 49.6/100 | 48.5/100 |
| Grade | C | C |
| Scorecard rank | #491 | #486 |
| Semaglutide | $151/mo (quarterly plan, plus a separate fee, compounded) | Pricing not published |
| Tirzepatide | Not disclosed | Pricing not published |
| Coverage | Coverage not published | 49 states (not Louisiana) |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #491 · C
Strengths
- Insurance coordination for brand-name GLP-1s — as low as $25/mo
- All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
- HSA and FSA accepted
- Video visits available with providers averaging 10+ years' experience
- Compounded semaglutide from $151/mo on the quarterly plan
Where it loses points
- Active FTC/DOJ lawsuit over deceptive billing and subscription practices
- Novo Nordisk false-advertising lawsuit (Aug 2025)
- Parent company Zealthy holds a BBB D- rating with 2,370+ complaints
- Trustpilot 2.0/5, with 85% one-star reviews citing billing disputes and unreachable support
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Graded #486 · C
Strengths
- Both molecules in BOTH routes — compounded semaglutide and tirzepatide as injections and as oral dissolving tablets
- Four branded pens on the same account: Mounjaro, Ozempic, Wegovy and Zepbound
- Sermorelin offered alongside the GLP-1 line
- 24/7 phone support on a published number
Where it loses points
- No price appears anywhere on the public site — /pricing 404s and every product CTA leads to a 2-minute intake quiz, so no cost can be compared before signing up
- The site contradicts itself on coverage: the homepage says "Serving All 50 States" while its own FAQ says 49 states and excludes Louisiana
- The four clinicians presented as "board-certified obesity specialists" are listed as Cardiac Surgery, Pediatric Clinic, Gynecology and Cardiac Surgery — none in obesity medicine
- "100% Customer Satisfaction" is stated as a headline fact and is not a substantiable claim
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.